Roche cutting jobs in product development: Report Ruchika Sharma12 Feb 2024 2:06 PM ISTZurich: Roche is cutting 345 jobs, Swiss website Muula reported, as the drugs company responds to lower profit posted for 2023 and a more cautious...
Modify Clinical Study Protocol: CDSCO Panel Tells Roche On Multiple Sclerosis Drug Ocrelizumab Dr. Divya Colin11 Feb 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by drug major Roche to conduct the Phase IV clinical trial for the drug product Ocrelizumab 300 mg...
Conduct India-specific Trial: CDSCO Panel Tells Roche on Satralizumab to Treat neuromyelitisoptica spectrum disorders Dr. Divya Colin8 Feb 2024 6:00 PM ISTNew Delhi: With an aim to establish the safety and efficacy of the Monoclonal Antibody Satralizumab in Indian patients, the Subject Expert Committee...
CDSCO Panel Approves Roche's Protocol Amendment Proposal for Anticancer Drug Giredestrant Dr. Divya Colin4 Feb 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Roche's proposal for marketing Atezolizumab Injection for Subcutaneous route rejected by CDSCO Panel Dr. Divya Colin27 Jan 2024 6:00 PM ISTNew Delhi: Rejecting the drug major Roche's proposal to market the anti-cancer drug Atezolizumab Injection (1875mg/15ml vial) (Tecentriq) for a new...
Roche gets European Commission marketing nod for Tecentriq SC for multiple cancer types Ruchika Sharma20 Jan 2024 11:24 AM ISTBasel: Roche has announced that the European Commission has granted marketing authorisation for Tecentriq SC (atezolizumab), the European Union (EU)'s...
Novel antibiotic class promising against invasive infections caused by carbapenem-resistant Acinetobacter: Study Medha Baranwal8 Jan 2024 3:45 AM ISTSwitzerland: A team of researchers from Swiss drugmaker Roche have identified a novel class of antibiotics that target a highly drug-resistant and...
Roche Gets CDSCO Panel Nod to Study anti-cancer Drug Giredestrant for Breast Cancer Dr. Divya Colin7 Jan 2024 6:00 PM ISTNew Delhi: The drug major Roche has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Roche enters into agreement to acquire LumiraDx Point of Care technology combining multiple diagnostic modalities on single platform Ruchika Sharma30 Dec 2023 11:27 AM ISTBasel: Roche has announced the entry into a definitive agreement to acquire select parts of the LumiraDx group related to LumiraDx's innovative...
Roche Xolair gets USFDA priority review for children, adults with food allergies Ruchika Sharma20 Dec 2023 12:41 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted, under Priority Review, the company's supplemental...
Roche Gets CDSCO Panel Nod to Study anti-cancer Drug Inavolisib Dr. Divya Colin12 Dec 2023 6:00 PM ISTNew Delhi: The drug major Roche has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Roche joins race for obesity drugs with USD 2.7 billion Carmot deal Ruchika Sharma5 Dec 2023 1:30 PM ISTRoche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to...
